<DOC>
	<DOC>NCT00548925</DOC>
	<brief_summary>The purpose of this study is to evaluate the safety and efficacy of a 6 mg twice a day dose of an investigational product in subjects with diabetic neuropathy</brief_summary>
	<brief_title>A Safety and Efficacy Study in Subjects With Diabetic Neuropathic Pain</brief_title>
	<detailed_description />
	<mesh_term>Neuralgia</mesh_term>
	<criteria>Males and females, age 18 to 75 If female, must be of nonchildbearing potential or practicing birth control Has diabetes mellitus (Type 1 or 2) and a diagnosis of painful distal symmetric diabetic polyneuropathy Has had pain from distal symmetric diabetic polyneuropathy for a minimum of 6 months Must be willing to washout of all analgesic medications prior to entry into the study Has other conditions that may cause pain Currently receiving analgesic medications for conditions other than diabetic neuropathic pain Has a history of certain psychiatric diseases Has a history of certain heart or cardiovascular conditions Has any clinically significant recent infection, injury, or illness Current participation in another clinical study or participation within the past 30 days Is incapacitated, bedridden or confined to a wheelchair Is pregnant and/or breastfeeding Previous participation in this study or any other study with this investigational product.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2013</verification_date>
</DOC>